About Us - Executive Management Team
The Executive Management Team manages Glide Pharma's activities and is led by the Chief Executive Officer (CEO). Each member of the team reports to the CEO.
Chief Executive Officer: Dr Charles Potter MA PhD
Charles is the inventor of the Glide technology and founder of Glide Pharma. He holds an engineering degree and PhD from Cambridge University. Charles spent six years undertaking research within the Transplant Unit at Papworth Hospital, a specialist cardiothoracic centre, where he gained extensive medical experience. Charles has worked in four other successful start-up companies including nearly six years at PowderJect Pharmaceuticals where he saw the company grow from just five employees to over 1000. charles.potter@glidepharma.com
Chief Financial Officer: Simon Jones BSc ACA
Following a degree in physics, Simon joined Ernst and Young where he qualified as a Chartered Accountant. Simon held a number of senior posts with Unipart. He joined Oxonica in 2000 as CFO and was involved with several fundraising rounds and the commercial development of the company including negotiating IP in-licensing and out-licensing agreements and the first major sales contract for the lead product to market. Up until the time that he left last year, Simon saw the company grow from six to 30 employees. simon.jones@glidepharma.com
Product Development Director: Dr Shohre Nabahi MSc Pharm D MRPharmS
Shohre is a pharmacist with more than twenty years of experience within product development and regulatory operations. She joined Glide Pharma from Phaeton Research where she held the position of Operations Director. Prior to Phaeton Shohre worked within the licensing division of MHRA and held senior management and development position as Director of Pharmaceutical Sciences at PowderJect Technologies. Before joining PowderJect she held positions of Section Head, Pharmaceutical R&D at Hoechst Marion Roussel and Development Pharmacist at Revlon Healthcare. shohre.nabahi@glidepharma.com
